A new cancer drug that extended median survival from six months to eleven months was celebrated with standing ovations at a national oncology conference.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.